Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III ... - PR-CANADA.net (press release) |
![]() |
PR-CANADA.net (press release)Relaxin, which is administered to hospitalized patients via a 48-hour infusion, has been shown to cause an increase in cardiac output, systemic and renal ... read more |